Dora Talvard
Dora Talvard
My work is focused on the life sciences and healthcare sectors. I advise clients on a broad range of regulatory aspects. I work hand in hand with the intellectual property, data protection, commercial and corporate lawyers of the firm to provide clients with tailor made advice and solutions.
7
Articles
0
Comments
Transfer of value in France: publication of the regulatory provisions specifying the ceilings above which an authorization from the authorities is required
An important change to the new regime governing transfer of value to HCPs, students and associations...
August 20, 2020
2 min read
Transfer of value in France: the long-awaited “anti-gift” decree has finally been published
The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the...
June 19, 2020
2 min read
COVID-19: ANSM guidance on Data Protection requirements for on-going trials
ANSM guidance underlines that adjustments to on-going clinical trials in the context of Covid-19...
April 20, 2020
4 min read
Transfers of value to “influencers”: new disclosure obligation for companies in the health sector
The list of beneficiaries of transfers of value subject to compulsory disclosure in the French public...
January 21, 2020
2 min read
The French Health Data Hub becomes reality
The French Health Data Hub was born officially with the publication on 30 November 2019 of a ministerial...
December 5, 2019
4 min read
Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
The French so-called “anti-gift” provisions strictly frame the conditions under which companies...
July 2, 2019
2 min read
Telemedicine in France: state of play
Telemedicine is governed by Article L6316-1 and R6316-1 and seq of the French public health code...
March 6, 2019
3 min read